Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Ending Sales of Tobacco Products in Pharmacies

Ending Sales of Tobacco Products in Pharmacies Opinion VIEWPOINT There is little doubt that reducing the morbidity and harsh light on pharmacies’ sale of cigarettes and other Troyen A. Brennan, mortality from tobacco use remains one of the most tobacco products. Advocates have long questioned the MD, MPH CVS Caremark, important public health challenges of the 21st century. juxtaposition of the distribution of medications for pro- Woonsocket, Rhode More than 480 000 deaths occur annually in the motinghealthwiththesaleofthesinglemostdeadlycon- Island. 1 5 United States as a result of smoking. There is essen- sumer product. Making cigarettes available in pharma- tially no such thing as moderate use of tobacco, which cies in essence “renormalizes” the product by sending Steven A. Schroeder, MD fuels addiction and illness, with enormous costs to the subtle message that it cannot be all that unhealthy Smoking Cessation society: $132 billion in direct medical costs and $157 if it is available for purchase where medicines are sold. Leadership Center, billion in lost productivity, according to recent The argument that pharmacies also sell tobacco- University of California, estimates. cessation products only heightens the paradox. This is San Francisco. Fifty years of tobacco control efforts have substan- primarily a US problem: pharmacies in other developed tially http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Ending Sales of Tobacco Products in Pharmacies

Brennan, Troyen A.; Schroeder, Steven A.
JAMA , Volume 311 (11) – Mar 19, 2014
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/ending-sales-of-tobacco-products-in-pharmacies-UiK6l3wbkG

References (6)

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2014.686
pmid
24500655
Publisher site
See Article on Publisher Site

Abstract

Opinion VIEWPOINT There is little doubt that reducing the morbidity and harsh light on pharmacies’ sale of cigarettes and other Troyen A. Brennan, mortality from tobacco use remains one of the most tobacco products. Advocates have long questioned the MD, MPH CVS Caremark, important public health challenges of the 21st century. juxtaposition of the distribution of medications for pro- Woonsocket, Rhode More than 480 000 deaths occur annually in the motinghealthwiththesaleofthesinglemostdeadlycon- Island. 1 5 United States as a result of smoking. There is essen- sumer product. Making cigarettes available in pharma- tially no such thing as moderate use of tobacco, which cies in essence “renormalizes” the product by sending Steven A. Schroeder, MD fuels addiction and illness, with enormous costs to the subtle message that it cannot be all that unhealthy Smoking Cessation society: $132 billion in direct medical costs and $157 if it is available for purchase where medicines are sold. Leadership Center, billion in lost productivity, according to recent The argument that pharmacies also sell tobacco- University of California, estimates. cessation products only heightens the paradox. This is San Francisco. Fifty years of tobacco control efforts have substan- primarily a US problem: pharmacies in other developed tially

Journal

JAMA – American Medical Association

Published: Mar 19, 2014

There are no references for this article.